Withanolide derivatives from the roots of Withania somnifera and their neurite outgrowth activities

Chemical and Pharmaceutical Bulletin

Volumn 50, Issue 6, 2002, Pages 760-765

  Zhao, Jing ^a   Nakamura, Norio ^a   Hattori, Masao ^a   Kuboyama, Tomoharu ^a   Tohda, Chihiro ^a   Komatsu, Katsuko ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Neurite outgrowth activity; Solanaceae; Withania somnifera; Withanolide; Withanoside

Indexed keywords

1ALPHA,3BETA.20,27 TETRAHYDROWITHA 5,24 DIENOLIDE 3 O BETA GLUCOPYRANOSIDE; 27 O BETA GLUCOPYRANOSYL (1-6) BETA GLUCOPYRANOSYLPUBESENOLIDE 3 O BETA GLUCOPYRANOSYL (1-6) BETA GLUCOPYRANOSIDE; 27 O BETA GLUCOPYRANOSYLPUBESENOLIDE 3 O BETA GLUCOPYRANOSIDE; 27 O BETA GLUCOPYRANOSYLPUBESENOLIDE 3 O BETA GLUCOPYRANOSYL (1-6) BETA GLUCOPYRANOSIDE; 3ALPHA,6ALPHA EPOXY 4BETA,5BETA,27 TRIHYDROXY 1 OXOWITH 24 ENOLIDE; 4BETA,5BETA,6ALPHA,27 TETRAHYDROXY 1 OXOWITHA 2,24 DIENOLIDE; COAGULIN Q; UNCLASSIFIED DRUG; WITHANIA SOMNIFERA EXTRACT; WITHANOLIDE; WITHANOLIDE A; WITHANOSIDE IV; WITHANOSIDE VI; 3 RHAMNOPYRANOSYL(1 4) GLUCOPYRANOSYL 12 DIACETOXY 20 HYDROXYWITHA 5,24 DIENOLIDE; 3-RHAMNOPYRANOSYL(1-4)-GLUCOPYRANOSYL-12-DIACETOXY-20-HYDROXYWITHA-5,24-DIENOLIDE; DISACCHARIDE; DRUG DERIVATIVE; ERGOSTEROL; LACTONE;

ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DETERMINATION; DRUG ISOLATION; HUMAN; HUMAN CELL; NERVE FIBER GROWTH; NEUROBLASTOMA CELL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSICAL CHEMISTRY; PLANT ROOT; TUMOR CELL CULTURE; WITHANIA SOMNIFERA; ANGIOSPERM; CELL CULTURE; CHEMISTRY; DRUG EFFECT; NEURITE;

DISACCHARIDES; ERGOSTEROL; HUMANS; LACTONES; NEURITES; PLANT ROOTS; SOLANACEAE; TUMOR CELLS, CULTURED;

EID: 0036593450     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.50.760     Document Type: Article

References (15)

1. Tohda C., Nakamura N., Komatsu K., Hattori M., Biol. Pharm. Bull., 22, 679-682 (1999).
2. Schliebs R., Liebmann A., Bhattacharya S. K., Kumar A., Ghosal S., Bigl V., Neurochem. Int., 30, 181-190 (1997).
3. Tohda C., Kuboyama T., Komatsu K., Neuro Report, 11, 1981-1985 (2000).
4. Subramanian S. S., Sethi P. D., Glotter E., Kirson I., Lavie D., Phytochemistry, 10, 685-688 (1971).
5. Kirson I., Glotter E., Lavie D., J. Chem. Soc. (C), 1971, 2032-2044 (1971).
6. Hansel R., Huang J. T., Rosenberg D., Arch. Pharm., 308, 653-654 (1975).
7. Neogi P., Kawai M., Butsugan Y., Mori Y., Suzuki M., Bull. Chem. Soc. Jpn., 61, 4479-4481 (1988).
8. Kuroyanagi M., Shibata K., Umehara K., Chem. Pharm. Bull., 47, 1646-1649 (1999).
9. Lavie D., Kirson I., Glotter E., Israel J. Chem., 6, 671-678 (1968).
10. Lavie D., Glotter E., Shvo Y., J. Org. Chem., 30, 1774-1778 (1965).
11. Matsuda H., Murakami T., Kishi A., Yoshikawa M., Bioorg. Med. Chem., 9, 1499-1507 (2001).
12. Atta-ur-Rahman, Shabbir M., Yousaf M., Qureshi S., e-Shahwar D., Naz A., Choudhary M. I., Phytochemistry, 52, 1361-1364 (1999).
13. Shingu K., Yahara S., Nohara T., Okabe H., Chem. Pharm. Bull., 40, 2088-2091 (1992).
14. Atta-ur-Rahman, Abbas S., e-Shahwar D., Jamal S. A., Choudhary M. I., J. Nat. Prod., 56, 1000-1006 (1993).
15. Ma C. M., Nakamura N., Hattori M., Chem. Pharm. Bull., 46, 982-987 (1998).